Verley has received a “no-questions” approval letter from the FDA for its precision fermented dairy proteins, clearing the way for the French startup to introduce its innovative alternative dairy ingredients to the US market. The approval covers Verley’s flagship products, including FermWhey Native, an animal-free whey protein, and FermWhey MicroStab, the first-ever UHT-stable recombinant whey protein. The company's proteins are said to be nutritionally identical to traditional dairy, but with superior functionality.

The fast turnaround after applying for Generally Recognized As Safe (GRAS) status in 2025 showcases the quality and robustness of Verley's submission. With a focus on B2B collaborations, Verley plans to initially introduce their ingredients in protein shots and high-protein yogurts. Additionally, the company's precision fermented proteins have been shown to be more environmentally friendly than animal-derived dairy, emitting fewer emissions, requiring less water, and taking up less land, making them suitable for vegans.